ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

LncRNA KCNQ1OT1: Molecular mechanisms and pathogenic roles in human diseases

Xia, Fangqi; Wang, Yaqi; Xue, Mengzhen; Zhu, Leiqi; Jia, Dengke; Shi, Yue; Gao, Yan; Li, Luoying; Li, Yuanyang; Chen, Silong; Xu, Guangfu; Yuan, Ding*; Yuan, Chengfu*中国医科大学
Genes & Diseases2022-11DOI: 10.1016/j.gendis.2021.07.003
7被引9阅读
引用收藏
分享

摘要

Long non-coding RNAs (lncRNAs) exhibit a length more than 200 nucleotides and they are characterized by non-coding RNAs (ncRNA) not encoded into proteins. Over the past few years, the role and development of lncRNAs have aroused the rising attention of re-searchers. To be specific, KCNQ1OT1, the KCNQ1 opposite strand/antisense transcript 1, is clearly classified as a regulatory ncRNA. KCNQ1OT1 is capable of interacting with miRNAs, RNAs and proteins, thereby affecting gene expression and various cell functions (e.g., cell prolifer-ation, migration, epithelial-mesenchymal transition (EMT), apoptosis, viability, autophagy and inflammation). KCNQ1OT1 is dysregulated in a wide range of human diseases (e.g., cardio-vascular disease, cancer, diabetes, osteoarthritis, osteoporosis and cataract), and it is specu-lated to act as a therapeutic target for treating various human diseases. On the whole, this review aims to explore the biological functions, underlying mechanisms and pathogenic roles of KCNQ1OT1 in human diseases.Copy

学科与关键词

关键词
Cell functionsHuman diseasesKCNQ1OT1Long non-coding RNARegulatory ncRNA
相关
加载中…
  • Biological role of long non-coding RNA KCNQ1OT1 in cancer progression
    Zhan, Kai; Pan, Huafeng; Zhou, Zhang; Tang, Wenqian; Ye, Zhining; Huang, Shaogang; Luo, Lei*Biomedicine and Pharmacotherapy, 2023, 169: 115876.
  • KCNQ1OT1在肿瘤中的表达及意义
    胡增涛; 徐书婉; 夏浩明; 高泽玮; 黄荣菊; 唐恩雨; 姜兴明实用药物与临床, 2019, (11): 1226-1229.
  • LncRNA KCNQ1OT1 regulates the invasion and migration of hepatocellular carcinoma by acting on S1PR1 through miR-149
    Cheng, Ji-Lun; Li, Du-Juan; Lv, Ming-Yang; Pei, Yi-Jin; Zhang, Xiu-Juan; Li, Lin; Liu, Xiang-Yu; Fan, Ai-Hui*Cancer Gene Therapy, 2021, 28(7-8): 850-863.被引 15
查看全部 →

发表信息

论文状态
公开发表
期刊
Genes & Diseases
发表日期
2022-11
卷期
第 9 卷, 第 6 期
页码
1556-1565
DOI
10.1016/j.gendis.2021.07.003
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81773959, 81974528, 2020ZYYD016]; Health commission of Hubei Province scientific research project in PR China [WJ2019H527]

作者

  • X

    Xia, Fangqi (第一作者)

    china three gorges univ

  • W

    Wang, Yaqi

    china three gorges univ

查看全部 13 位作者收起作者
  • X

    Xue, Mengzhen

    china three gorges univ

  • Z

    Zhu, Leiqi

    china three gorges univ

  • J

    Jia, Dengke

    china three gorges univ

  • S

    Shi, Yue

    china three gorges univ

  • G

    Gao, Yan

    china three gorges univ

  • L

    Li, Luoying

    china three gorges univ

  • L

    Li, Yuanyang

    china three gorges univ

  • C

    Chen, Silong

    china three gorges univ

  • X

    Xu, Guangfu

    china three gorges univ

  • Y

    Yuan, Ding (通讯)

    china three gorges univ

  • Y

    Yuan, Chengfu (通讯)

    china three gorges univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417